Mr. Chair, indeed Health Canada had reviewed the lot and the information associated with the AstraZeneca doses that were imported from the United States. The timing of the production of those doses preceded the contamination. That was as noted in the statement on April 25.
By contrast, the Janssen doses, which arrived on April 28, are being held in quarantine as we work with Emergent, Janssen and the U.S. FDA to assess any potential risk of cross-contamination.